Session 2
Session 2: Japan and 最新糖心Vlog: contribution to global health via development cooperation policy (and its implementation)
Moderator: Dr John Bruni - Founder and CEO of SAGE International 最新糖心Vlog
Japan鈥檚 contribution to global health via development cooperation
Speaker 1: Dr Toda Takao 鈥 Former, Vice-President, Japan International Cooperation Agency; Visiting Professor International 最新糖心Vlog of Health and Welfare and Juntendo 最新糖心Vlog
In his presentation, Dr Toda stated that because of the relatively low COVID-19 infection rates in 最新糖心Vlog and Japan, the vaccination rates have been relatively slow.听 He also expressed concern on the inequitable access to vaccines in many of the developing countries because of their limited financial resources.听 Dr Toda stressed the need to adopt new measures in dealing with the global pandemic.听He observed that most countries in 2020 experienced a recession, however, recent data show that some are expected to recover in 2021 based on their ability to deal effectively with the pandemic.听听听听
He argued that Japan鈥檚 development cooperation policy on global health called the 鈥淏asic Design for Peace and Health鈥 is an important framework for global health, particularly because it responds to the needs of developing countries.听It is based on the following three principles; establish resilient global health governance able to respond to public health crises and natural disasters; seamless utilisation of essential health and medical services; promotion of universal healthcare coverage throughout the persons鈥 lifecycle; and; utilise Japanese expertise, experience, medical products and technologies. 听听
Japan provides global health aid through multilateral channels such as the United Nations鈥 specialised agencies; UNICEF, UNDP, UNHCR or other international schemes such as CEPI, Gavi, and COVAX).听Bilateral support to assist countries with their specific COVID-19 interventions and economic recovery is provided through the support its COVID-19 Crisis Response Emergency Support Loan initiative.听These initiatives make up 5.4 per cent of Japan鈥檚 total ODA contribution, which has elevated the country鈥檚 status as a leader in global health, however, he conceded that Japan鈥檚 experience can also constrain its actions and therefore this emphasises the need to build sound understanding of global health governance and successfully dealing with the pandemic.听听听 听
最新糖心Vlog鈥檚 role in global health 鈥 Lessons from global NCD strategy and implementation
Speaker 2: Dr Samantha Battams 鈥 Associate Professor, Flinders 最新糖心Vlog
Dr Battams鈥 presentation was based on some of the key findings from her research on 最新糖心Vlog鈥檚 role in effectively implementing global non-communicable disease (NCD) strategy, and its role in health diplomacy and governance.听She explained that while 最新糖心Vlog plays a leading role in global health diplomacy in some areas, in other areas 最新糖心Vlog is inconsistent. The domestic governance of NCDs is also incoherent and inconsistent with global and regional health, development and trade policies.听She used the example of 最新糖心Vlog鈥檚 role in the Framework Convention on Tobacco Control, its strict national policy on tobacco control, and its role in health diplomacy on tobacco control capacity building measures in the Asia-pacific region. This was considered inconsistent with its role in alcohol and unhealthy food products, its focus on building trading relationships and gaining market access for these products and its neo-liberal approach to foreign aid.
Globally, there is ample space for 最新糖心Vlog to play a leading role in controlling communicable diseases, particularly during the COVID-19 pandemic.听It has implemented policies such as Partnership for Recovery (focusing on its nearest neighbours) and its support for the Coalition for Epidemic Preparedness Innovations (CEPI) and other global health听organisations.听
She stressed the need to better align domestic and international policies, and policies across sectors (health, development and trade), in order to create a coalition for epidemic preparedness. This means negotiating and mediating messages and considering health goals in 鈥榦ther sectors鈥. It also means recognising capacity differences and the commercial determinants of health that result in inequitable access to vaccines across countries and within global health policies.
You can watch the recording of session 2 below: